a positive trendp=0.08
Furthermore, the combination of low-dose RT 2×2 Gy to primary tumors with anti-PD-L1 showed a positive trend in the growth of secondary tumors compared with anti-PD-L1 alone ((2×2 Gy+anti-PD-L1) vs (NIR+anti-PD-L1): p=0.08).
Furthermore, the combination of low-dose RT 2×2 Gy to primary tumors with anti-PD-L1 showed a positive trend in the growth of secondary tumors compared with anti-PD-L1 alone ((2×2 Gy+anti-PD-L1) vs (NIR+anti-PD-L1): p=0.08).